Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

York University

$28,750.00

Dual role of vascular endothelial growth factor family members and angiomotion in vascular and muscular plasticity during rodent skeletal muscle remodeling

FY 2009-10

Summary
Skeletal muscle rapidly adapts to variations of the functional demand with a remarkable plasticity that can be evidenced by changes in capillarity and myofibres' properties. Myofibres produce vascular endothelial growth factor-A (VEGF-A), a key initiator of muscular angiogenesis, i.e. the de novo synthesis of blood capillaries. VEGF-A also ensures the maintenance of established capillaries. During skeletal muscle remodeling, myofibres could thus adjust muscle capillarity mainly by modulating VEGF-A expression that would in turn either enhance angiogenesis or induce vascular regression. However this relationship between myofibres, VEGF-A and capillaries is likely much more complex. Recent evidences suggest that the modulation of muscle capillarity, secondary to VEGF-A expression by myofibres, could control changes in the myofibres' contractile phenotype. In addition, recent data have shown that VEGF-A could also affect the metabolic properties of muscle cells. I therefore hypothesize that VEGF-A expression by myofibres will affect both their contractile and metabolic phenotypes during skeletal muscle remodeling. Moreover, regression, maintenance or stimulation of muscle capillarity cannot be explained by VEGF-A alone. Among angiogenesis factors, the vascular endothelial growth factor-B and angiomotin are highly expressed in skeletal muscle. Furthermore, their action is not restricted to capillarity regulation only. I thus hypothesize that aside from their involvement in angiogenesis, these molecules could play a role in muscle cells remodeling. The overall aim of my research program is to investigate whether VEGF-A, VEGF-B and angiomotin, initially described during angiogenesis, play a dual role on capillaries and myofibres. Thus, by acting on both endothelial cells and myocytes, they could be of critical importance for muscle remodeling. The program presented in this NSERC proposal will bring new knowledge in understanding the fundamental roles played by these molecules on both muscular and vascular plasticity during rodent skeletal muscle remodeling.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
341258-2007
Name nom
Birot, Olivier
Department département
Health, Faculty of
Organization id
38
Institution établissement
York University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2007
Award amount
28750
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1011
Committee name en
Integrative Animal Biology
Committee name fr
Biologie Animale Intégrative
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5500
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal biology
Research subject fr
Biologie animale
Partie
3
Nb partie
3
Application title
Dual role of vascular endothelial growth factor family members and angiomotion in vascular and muscular plasticity during rodent skeletal muscle remodeling
Keyword
NA
Application summary
Skeletal muscle rapidly adapts to variations of the functional demand with a remarkable plasticity that can be evidenced by changes in capillarity and myofibres' properties. Myofibres produce vascular endothelial growth factor-A (VEGF-A), a key initiator of muscular angiogenesis, i.e. the de novo synthesis of blood capillaries. VEGF-A also ensures the maintenance of established capillaries. During skeletal muscle remodeling, myofibres could thus adjust muscle capillarity mainly by modulating VEGF-A expression that would in turn either enhance angiogenesis or induce vascular regression. However this relationship between myofibres, VEGF-A and capillaries is likely much more complex. Recent evidences suggest that the modulation of muscle capillarity, secondary to VEGF-A expression by myofibres, could control changes in the myofibres' contractile phenotype. In addition, recent data have shown that VEGF-A could also affect the metabolic properties of muscle cells. I therefore hypothesize that VEGF-A expression by myofibres will affect both their contractile and metabolic phenotypes during skeletal muscle remodeling. Moreover, regression, maintenance or stimulation of muscle capillarity cannot be explained by VEGF-A alone. Among angiogenesis factors, the vascular endothelial growth factor-B and angiomotin are highly expressed in skeletal muscle. Furthermore, their action is not restricted to capillarity regulation only. I thus hypothesize that aside from their involvement in angiogenesis, these molecules could play a role in muscle cells remodeling. The overall aim of my research program is to investigate whether VEGF-A, VEGF-B and angiomotin, initially described during angiogenesis, play a dual role on capillaries and myofibres. Thus, by acting on both endothelial cells and myocytes, they could be of critical importance for muscle remodeling. The program presented in this NSERC proposal will bring new knowledge in understanding the fundamental roles played by these molecules on both muscular and vascular plasticity during rodent skeletal muscle remodeling.
York University - $28,750 Grant (2009-10) | Canada Spends